Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 1)
Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 49884-186
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 49884-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 2)
Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 3)
This is a medication with NDC number 49884-186-01, named LA186-01.74-01. Each delayed-release tablet coated with film contains 10mg of Doxylamine Succinate and Pyridoxine Hydrochloride. The usual dosage is to take two tablets at bedtime, but the dose can be increased to four tablets daily for inadequate symptom control. The medication should be stored at 20 to 25°C (68° to 77°F) and protected from moisture and light. It is important to swallow the whole tablet - not to crush or chew it. This medication should be kept away from children. The package includes 100 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
